erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the http://lm360.us/Buzzanca-sister-of-Rackow-from-Garup?Miliusdau=191
the medical experts are worse. their pretense of idealism knows no limits, and is matched only by their claim to bullet-proof knowledge.
.ai-based software may help predict risk of dementia
.
.more stories from investigations
.